213 related articles for article (PubMed ID: 14678602)
21. Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity.
Lopalco L; Pastori C; Cosma A; Burastero SE; Capiluppi B; Boeri E; Beretta A; Lazzarin A; Siccardi AG
AIDS Res Hum Retroviruses; 2000 Jan; 16(2):109-15. PubMed ID: 10659050
[TBL] [Abstract][Full Text] [Related]
22. Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E.
Wang S; Pal R; Mascola JR; Chou TH; Mboudjeka I; Shen S; Liu Q; Whitney S; Keen T; Nair BC; Kalyanaraman VS; Markham P; Lu S
Virology; 2006 Jun; 350(1):34-47. PubMed ID: 16616287
[TBL] [Abstract][Full Text] [Related]
23. Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system.
Yang CW; Oh EJ; Lee SB; Moon IS; Kim DG; Choi BS; Park SC; Choi YJ; Park YJ; Han K
Transplant Proc; 2006 Nov; 38(9):2803-6. PubMed ID: 17112834
[TBL] [Abstract][Full Text] [Related]
24. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
[TBL] [Abstract][Full Text] [Related]
25. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
[TBL] [Abstract][Full Text] [Related]
26. Detection and specification of noncomplement binding anti-HLA alloantibodies.
Arnold ML; Zacher T; Dechant M; Kalden JR; Doxiadis II; Spriewald BM
Hum Immunol; 2004 Nov; 65(11):1288-96. PubMed ID: 15556679
[TBL] [Abstract][Full Text] [Related]
27. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF
Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719
[TBL] [Abstract][Full Text] [Related]
28. The modulation of human aortic endothelial cell ICAM-1 (CD-54) expression by serum containing high titers of anti-HLA antibodies.
Hosenpud JD; Shipley GD; Morris TE; Hefeneider SH; Wagner CR
Transplantation; 1993 Feb; 55(2):405-11. PubMed ID: 7679530
[TBL] [Abstract][Full Text] [Related]
29. Immunoglobulin G subclass analysis of HLA donor specific antibodies in heart and renal transplant recipients.
Cicciarelli JC; Kasahara N; Lemp NA; Adamson R; Dembitsky W; Browne B; Steinberg S
Clin Transpl; 2013; ():413-22. PubMed ID: 25095537
[TBL] [Abstract][Full Text] [Related]
30. Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients.
Ravindranath MH; Pham T; Ozawa M; Terasaki PI
Int Immunol; 2012 Jan; 24(1):43-57. PubMed ID: 22190577
[TBL] [Abstract][Full Text] [Related]
31. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S
Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320
[TBL] [Abstract][Full Text] [Related]
32. Decreased anti-donor major histocompatibility complex class I and increased class II alloantibody response in allograft tolerance in adult rats.
Cuturi MC; Josien R; Cantarovich D; Bugeon L; Anegon I; Menoret S; Smit H; Douillard P; Soulillou JP
Eur J Immunol; 1994 Jul; 24(7):1627-31. PubMed ID: 8026523
[TBL] [Abstract][Full Text] [Related]
33. Donor non-specific MICA antibodies in renal transplant recipients.
Sapák M; Chreňová S; Tirpáková J; Žilinská Z; Ďurmanová V; Shawkatová I; Jakuš V; Kuba D; Buc M
Immunobiology; 2014 Feb; 219(2):109-12. PubMed ID: 24054943
[TBL] [Abstract][Full Text] [Related]
34. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
[TBL] [Abstract][Full Text] [Related]
35. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
Süsal C; Döhler B; Opelz G
Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
[TBL] [Abstract][Full Text] [Related]
36. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
[TBL] [Abstract][Full Text] [Related]
37. Immunoglobulin isotype-specific characterization of anti-human leukocyte antigen antibodies eluted from explanted renal allografts.
Heinemann FM; Roth I; Rebmann V; Arnold ML; Witzke O; Wilde B; Spriewald BM; Grosse-Wilde H
Hum Immunol; 2007 Jun; 68(6):500-6. PubMed ID: 17509449
[TBL] [Abstract][Full Text] [Related]
38. Algorithm to manage highly sensitized kidney transplant recipients in Poland.
Zielińska H; Moszkowska G; Zieliński M; Debska-Ślizień A; Rutkowski B; Trzonkowski P
Transplant Proc; 2011 Oct; 43(8):2903-7. PubMed ID: 21996185
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and qualitative properties of circulating anti-human leukocyte antigen alloantibodies after pregnancy: no association with unexplained recurrent miscarriage.
Bartel G; Walch K; Wahrmann M; Pils S; Küssel L; Polterauer S; Tempfer C; Böhmig GA
Hum Immunol; 2011 Feb; 72(2):187-92. PubMed ID: 21075157
[TBL] [Abstract][Full Text] [Related]
40. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
